SOP-话题@MedSci

#SOP#

12篇内容 | 575人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1970344, encodeId=29d819e034460, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=检验科标本采集SOP文件，建议收藏！, objectType=article, longId=726658, objectId=5d96e26658cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d96e26658cf, replyNumber=0, likeNumber=45, createdTime=2022-11-11, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d96e26658cf, moduleTitle=检验科标本采集SOP文件，建议收藏！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d96e26658cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970343, encodeId=7dbf19e03434e, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=Avasopasem治疗放疗诱导的严重口腔粘膜炎，III期ROMAN试验未达到主要终点, objectType=article, longId=218974, objectId=f0e12189e46e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0e12189e46e, replyNumber=0, likeNumber=51, createdTime=2022-09-19, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0e12189e46e, moduleTitle=Avasopasem治疗放疗诱导的严重口腔粘膜炎，III期ROMAN试验未达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0e12189e46e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970342, encodeId=2b7819e0342af, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=MacroGenics宣布HER2单抗Margetuximab在转移性乳腺癌患者中的III期临床SOPHIA的第二次总体中期生存数据, objectType=article, longId=181811, objectId=3a1a18181105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a1a18181105, replyNumber=0, likeNumber=34, createdTime=2019-11-13, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a1a18181105, moduleTitle=MacroGenics宣布HER2单抗Margetuximab在转移性乳腺癌患者中的III期临床SOPHIA的第二次总体中期生存数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a1a18181105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970341, encodeId=61d819e0341b3, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=SOPHIA初步结果开辟HER2阳性晚期乳腺癌治疗新途径, objectType=article, longId=168401, objectId=633a16840184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=633a16840184, replyNumber=0, likeNumber=27, createdTime=2020-03-19, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=633a16840184, moduleTitle=SOPHIA初步结果开辟HER2阳性晚期乳腺癌治疗新途径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=633a16840184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970338, encodeId=ce5819e03389b, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=Sophiris Bio披露了前列腺癌II期研究中的死亡事件, objectType=article, longId=141736, objectId=6dc2141e36b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dc2141e36b3, replyNumber=0, likeNumber=45, createdTime=2018-08-23, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dc2141e36b3, moduleTitle=Sophiris Bio披露了前列腺癌II期研究中的死亡事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dc2141e36b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970339, encodeId=d9f919e03392f, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=Mallinckrodt的stannsoporfin被FDA拒之门外, objectType=article, longId=147346, objectId=c65714e3461c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c65714e3461c, replyNumber=0, likeNumber=35, createdTime=2019-03-26, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c65714e3461c, moduleTitle=Mallinckrodt的stannsoporfin被FDA拒之门外, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c65714e3461c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970340, encodeId=bed819e0340d3, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适, objectType=article, longId=149403, objectId=5d0f149403e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d0f149403e6, replyNumber=0, likeNumber=38, createdTime=2018-11-04, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d0f149403e6, moduleTitle=J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d0f149403e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970337, encodeId=aff019e033709, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=Neurology：神经急救SOP在撒哈拉以南非洲的应用, objectType=article, longId=101548, objectId=2d38101548e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d38101548e4, replyNumber=0, likeNumber=40, createdTime=2018-02-20, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d38101548e4, moduleTitle=Neurology：神经急救SOP在撒哈拉以南非洲的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d38101548e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970336, encodeId=bb9a19e0336bb, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=如何开展新药临床试验：从GCP，SOP到临床试验管理和质量控制, objectType=article, longId=52886, objectId=696d5288694, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=696d5288694, replyNumber=0, likeNumber=33, createdTime=2015-11-22, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=696d5288694, moduleTitle=如何开展新药临床试验：从GCP，SOP到临床试验管理和质量控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=696d5288694)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970335, encodeId=a60419e033561, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=临床试验有关SOP汇总, objectType=article, longId=32543, objectId=950e32543ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=950e32543ec, replyNumber=0, likeNumber=30, createdTime=2014-10-04, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=950e32543ec, moduleTitle=临床试验有关SOP汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=950e32543ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970333, encodeId=f36a19e033347, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=SOP(中英文对照), objectType=article, longId=552, objectId=bb6055246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb6055246, replyNumber=0, likeNumber=34, createdTime=2011-03-22, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb6055246, moduleTitle=SOP(中英文对照), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb6055246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970334, encodeId=ecbf19e033440, content=<a href='/topic/show?id=e8831654805' target=_blank style='color:#2F92EE;'>#SOP#</a>, objectTitle=临床试验或CRO领域的SOP翻译要求, objectType=article, longId=555, objectId=2e4955585, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e4955585, replyNumber=0, likeNumber=41, createdTime=2010-09-26, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e4955585, moduleTitle=临床试验或CRO领域的SOP翻译要求, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e4955585)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SOP

2020-05-29

neizongke (审核中...)

前往app查看评论内容

#SOP#

检验科标本采集SOP文件，建议收藏！

2022-11-11

neizongke (审核中...)

前往app查看评论内容

#SOP#

Avasopasem治疗放疗诱导的严重口腔粘膜炎，III期ROMAN试验未达到主要终点

2022-09-19

neizongke (审核中...)

前往app查看评论内容

#SOP#

MacroGenics宣布HER2单抗Margetuximab在转移性乳腺癌患者中的III期临床SOPHIA的第二次总体中期生存数据

2019-11-13

neizongke (审核中...)

前往app查看评论内容

#SOP#

SOPHIA初步结果开辟HER2阳性晚期乳腺癌治疗新途径

2020-03-19

neizongke (审核中...)

前往app查看评论内容

#SOP#

Sophiris Bio披露了前列腺癌II期研究中的死亡事件

2018-08-23

neizongke (审核中...)

前往app查看评论内容

#SOP#

Mallinckrodt的stannsoporfin被FDA拒之门外

2019-03-26

neizongke (审核中...)

前往app查看评论内容

#SOP#

J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适

2018-11-04

neizongke (审核中...)

前往app查看评论内容

#SOP#

Neurology：神经急救SOP在撒哈拉以南非洲的应用

2018-02-20

neizongke (审核中...)

前往app查看评论内容

#SOP#

如何开展新药临床试验：从GCP，SOP到临床试验管理和质量控制

2015-11-22

neizongke (审核中...)

前往app查看评论内容

#SOP#

临床试验有关SOP汇总

2014-10-04

neizongke (审核中...)

前往app查看评论内容

#SOP#

SOP(中英文对照)

2011-03-22

neizongke (审核中...)

前往app查看评论内容

#SOP#

临床试验或CRO领域的SOP翻译要求

2010-09-26

科室
- - 订阅+
  - 更多科室
工具
服务